Fast-casual Ohio-based US restaurant brand City BBQ has formed a partnership with customer data platform Bikky to drive ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

SINGAPORE - China’s BYD was the best-selling car brand in Singapore in 2024, with 6,191 units registered, beating out Japan’s Toyota and Germany’s BMW. This is the first time a Chinese ...

Your brand's ability and willingness to solve pain points for current and potential customers can make or break your company's existence and relevance in the industry. To help brand leaders remain ...

A statement on Saturday mentioned that the CM will use the platform to emphasize the state's strengths, including its human resources, infrastructure, government subsidies, stable leadership, and ...

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer ...

A low-key brand, founded by archaeologists in Wales, has quietly expanded in New York. By Thessaly La Force At the end of last year, the lifestyle brand Toast quietly opened its second store in ...

As we enter 2025, it is clearer than ever that in the back half of this decade, brand building and audience engagement will be rooted in the creation of brand-funded content and entertainment.

Sanofi and Regeneron’s checkpoint inhibitor Libtayo has become the first immunotherapy to improve survival when used as a second-line therapy in cervical cancer, setting up regulatory filings ...

Stray Kids’ leader Bang Chan has officially been named the new brand ambassador for Italian luxury fashion house Fendi! On January 16, Fendi made the exciting announcement through its social ...

Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab) led to a statistically ...